SCHEMBL850563

SCHEMBL850563

[N-]=[N+]=C(C(=O)Oc1ccc([N+](=O)[O-])cc1)C(F)(F)F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.47
BCL9 O00512 1/20 0.44
CTNNB1 P35222 1/20 0.44
KMT2A Q03164 4/20 0.43
PKM P14618 1/20 0.43
ALDH1A1 P00352 4/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSPB1 P04792 1/20 0.41
MAPT P10636 4/20 0.40
KCNH2 Q12809 1/20 0.40
MGLL Q99685 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CES2 O00748 1/20 0.40
CES1 P23141 1/20 0.40
HGFAC Q04756 1/20 0.39
MEN1 O00255 2/20 0.39
RAB9A P51151 2/20 0.39
NPC1 O15118 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7063519 0.78 GAA (0.65) GAABCL9CTNNB1KMT2APKM
SCHEMBL734833 0.77 GAA (0.56) GAABCL9CTNNB1KMT2APKM
P-Nitrophenol SCHEMBL6422008 0.75 TDP1 (0.41) GAAKMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL9496344 0.75 GAA (0.53) GAABCL9CTNNB1KMT2APKM
SCHEMBL9775366 0.75 GAA (0.53) GAABCL9CTNNB1KMT2APKM
Trifluoroacetic Acid SCHEMBL31064275 0.74 GAA (0.53) GAABCL9CTNNB1KMT2APKM
SCHEMBL181137 0.74 GAA (0.49) GAABCL9CTNNB1KMT2APKM
SCHEMBL8578508 0.73 GAA (0.59) GAABCL9CTNNB1KMT2APKM
P-Nitrophenol SCHEMBL6226065 0.73 GAA (0.51) GAABCL9CTNNB1KMT2APKM
SCHEMBL29003163 0.72 GAA (0.54) GAABCL9CTNNB1KMT2APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 753 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832201-B1 A SAMPLE PRESENTATION APPARATUS FOR MASS SPECTROMETRY UNIV ARIZONA (US) 2005-10-05 EP claimed
WO-2005086775-A2 LUMEN-EXPOSED MOLECULES AND METHODS FOR TARGETED DELIVERY UTAH VENTURES II, L.P. (US) 2005-09-22 WO claimed
US-20040146516-A1 Lumen-exposed molecules and methods for targeted delivery UTAH VENTURES II L.P. 2004-07-29 US claimed
WO-2002061045-A2 SIMPLIFIED METHOD FOR INDEXING AND DETERMINING THE RELATIVE CONCENTRATION OF EXPRESSED MESSENGER RNAS DIGITAL GENE TECHNOLOGIES, INC. (US) 2002-08-08 WO claimed
US-20020012922-A1 Simplified method for indexing and determining the relative concentration of expressed messenger RNAs NEUROME, INC. 2002-01-31 US claimed
US-6316266-B1 PROVIDING MASS SPECTROMETRY SAMPLE PRESENTATION METAL SURFACE; CONTACTING COMPLEX WITH SURFACE TO FORM A SURFACE-BOUND COMPLEX; CONTACTING BIOMOLECULE WITH COMPLEX; APPLYING MATRIX ASSISTED LASER DESORPTION/IONIZATION MATRIX; DETERMINATION ARIZONA STATE UNIVERSITY BOARD OF REGENTS 2001-11-13 US claimed
WO-2001083696-A2 METHODS FOR RAPID ISOLATION AND SEQUENCE DETERMINATION OF GENE-SPECIFIC SEQUENCES DIGITAL GENE TECH INC (US) 2001-11-08 WO claimed
US-6093541-A WITH METAL PRESENTATION SURFACE HAVING IMMOBILIZED COMPLEX OF TETHERING MOLECULE AND DIGESTION MOLECULE; FOR RAPID AND EFFICIENT ANALYSIS OF BIOMOLECULES USING MATRIX-ASSISTED LASER DESORPTION/IONIZATION TECHNIQUE ARIZONA STATE UNIVERSITY BOARD OF REGENTS (US) 2000-07-25 US claimed
US-6004770-A MASS SPECTROMETRY SAMPLE PRESENTATION APPARATUSES DERIVATIZED WITH COMPLEXES INCLUDING AT LEAST ONE MOLECULE WHICH MODIFIES A BIOMOLECULE ARIZONA STATE UNIVERSITY BOARD OF REGENTS (US) 1999-12-21 US claimed
US-5869348-A Methods for the preparation of antibodies directed against dithiocarbamates and the use thereof for detection of nitric oxide in body fluids MEDINOX, INC. (US) 1999-02-09 US claimed
US-5401634-A Stable biologically active fluorochemical emulsions MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1995-03-28 US claimed
EP-4746899-A1 TREATMENT OF CANCER PATIENTS WITH TUMOR INFILTRATING LYMPHOCYTE THERAPIES IN COMBINATION WITH TROP-2 TARGETING ADC Iovance Biotherapeutics, Inc. (US) 2026-05-27 EP disclosed
EP-4743565-A2 CYTOKINE ENCODING LENTIVIRAL VECTORS AND USES THEREOF FOR MAKING TUMOR INFILTRATING LYMPHOCYTES Iovance Biotherapeutics, Inc. (US) 2026-05-20 EP disclosed
WO-2026102297-A1 ANTIBODY OLIGONUCLEOTIDE CONJUGATES FOR TREATING DISEASE Fulcrum Therapeutics, Inc. (US) 2026-05-15 WO disclosed
EP-4735051-A1 COMPOSITIONS AND METHODS OF USING PLN-TARGETING ANTIBODY-OLIGONUCLEOTIDE CONJUGATES Atrium Therapeutics, Inc. (US) 2026-05-06 EP disclosed
US-4528267-A Fluorometirc enzyme inhibition immunoassay for measuring potency of allergen extracts AXIONICS, INC. (US) 1985-07-09 US disclosed
EP-0124103-A2 Fluorometric assay of chymopapain and reagents therefor BioWhittaker, Inc. (US) 1984-11-07 EP disclosed
EP-0119613-A2 Fluorometric assay of total IgE level and reagents therefor BioWhittaker, Inc. (US) 1984-09-26 EP disclosed
EP-0107832-A2 Stable allergenic extracts and methods MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1984-05-09 EP disclosed
EP-0106324-A2 Fluorometric assay of allergic reactions and reagents therefor MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1984-04-25 EP disclosed